BackTable / VI / Contributor

Dr. Terence Gade on the BackTable VI Podcast

Dr. Terence Gade

Interventional Radiologist

Dr. Terence Gade is a practicing interventional radiologist with at the University of Pennsylvania.

Listen to Dr. Terence Gade on the BackTable VI Podcast

The BackTable Podcast is a knowledge resource by physicians for physicians. Learn from the experiences and expertise of Dr. Terence Gade and get practical advice on how to build your practice by listening to the BackTable VI Podcast.

Ep 76 Targeting the Tumor Microenvironment in HCC with Dr. Terence Gade
00:00 / 01:04
BackTable CMEfy button

Stay Up To Date

Follow:

Subscribe:

Sign Up:

Podcasts Featuring Dr. Terence Gade

Episode #76

BackTable Podcast Play Button

Interventional Radiologist Terence Gade from Penn Medicine, University of Pennsylvania Health System tells us about emerging research and therapies targeting the tumor microenvironment in Hepatocellular carcinoma (HCC).

Episode #20

BackTable Podcast Play Button

Our 20th BackTable podcast episode featuring special guests Dr. Justin Lee of Florida Interventional Specialists, and Dr. Terence Gade of Hospital of University of Pennsylvania. They discuss experiences and utility of pressure-directed, antireflux infusion for TACE treatments.

Articles Featuring Dr. Terence Gade

Surefire infusion catheter for pressure directed therapy

Effective drug delivery systems attempt to maximize homogeneous distribution of the respective agent to the entire tumor to induce cytotoxicity and tumor necrosis. Dr. Justin Lee and Dr. Terence Gade discuss how pressure-directed therapy improves drug delivery to areas of tumor burden in cases of HCC.

3D image of hepatocellular carcinoma

Various treatment options exist for intermediate-stage HCC including lidiodal-based cTACE and DEB-TACE. Dr. Terence Gade discusses chemotherapeutic options, how tumor biology influences embolic delivery, and how these treatment modalities can be used to treat HCC.

TACE used to treat hepatocellular carcinoma

Transarterial chemoembolization (TACE) and radioembolization (Y90) have individualized roles in the treatment of hepatocellular carcinoma. Dr. Justin Lee and Dr. Terence Gade discuss which patients are best suited for TACE versus Y90, as well as the advantages and disadvantages for each intervention.

Get Connected

Thank you for listening! If you have a question for Dr. Terence Gade about a topic discussed on the BackTable VI Podcast, you can get in touch with this form. Please note that our contributors are not able to respond to every inquiry.

Select which show(s) you would like to subscribe to:

Thanks! Message sent.

Disclaimer: The Materials available on BackTable.com are for informational and educational purposes only and are not a substitute for the professional judgment of a healthcare professional in diagnosing and treating patients. The opinions expressed by participants of the BackTable Podcast belong solely to the participants, and do not necessarily reflect the views of BackTable.

Earn CME When You Listen to BackTable CMEfy

Podcasts

Targeting the Tumor Microenvironment in HCC with Dr. Terence Gade on the BackTable VI Podcast)
Pressure-Directed Therapy in TACE with Dr. Justin Lee and Dr. Terence Gade on the BackTable VI Podcast)
New Tools to Treat Severe Distal Femoropopliteal Disease with Dr. John Rundback on the BackTable VI Podcast)

Topics

Hepatocellular Carcinoma Condition Overview

More Contributors

Dr. Michael Barraza on the BackTable VI Podcast

Dr. Michael Barraza

Dr. Christopher Beck on the BackTable VI Podcast

Dr. Christopher Beck

Dr. Jennifer Berumen on the BackTable VI Podcast

Dr. Jennifer Berumen

Dr. Alex Kim on the BackTable VI Podcast

Dr. Alex Kim

Dr. Justin Lee on the BackTable VI Podcast

Dr. Justin Lee

Dr. Isabel Newton on the BackTable VI Podcast

Dr. Isabel Newton